Finland· FI-REL-REL7774

Kenacort-T

A triamcinolone product, registered in Finland by E.R. Squibb & Sons Limited. The same ATC class is registered in 7 of our 19 countries.

ATC D07AB09

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedKenacort-TATCD07AB09REGISTER NO.FI-REL-REL7774PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Triamcinolone is registered in 7 of 19 countries.

Countries holding a registration under ATC D07AB09 (triamcinolone), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 4 of them publish a price we can compare per daily dose

Triamcinolone · ATC D07AB09

7 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Germany
  • Netherlands
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Manufacturer
E.R. Squibb & Sons Limited
Country
Finland (FI)
ATC code
D07AB09
ATC class
Triamcinolone
Defined daily dose
2 mg, T
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

55 interactions on record for triamcinolone.

Graded by severity as the source publishes them — 55 minor. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Triamcinolone · interactions on record

55 records

Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9305e2d8-0fb5-412a-a2a9-1736d5d25e7c
GET /v1/drugs/9305e2d8-0fb5-412a-a2a9-1736d5d25e7c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "linimentti",
  "route": null,
  "ddd_unit": null,
  "strength": "1 mg/ml",
  "atc_label": "triamsinoloni",
  "ma_number": "2659",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL7774",
  "authorised_at": "1965-12-08"
}

See everything about triamcinolone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.